Teva Pharmaceutical Industries Receivables 2010-2024 | TEVA

Teva Pharmaceutical Industries receivables for the quarter ending December 31, 2024 were $3.059B, a 10.24% decline year-over-year.

  • Teva Pharmaceutical Industries receivables for 2024 were $3.059B, a 10.24% decline from 2023.
  • Teva Pharmaceutical Industries receivables for 2023 were $3.408B, a 7.79% decline from 2022.
  • Teva Pharmaceutical Industries receivables for 2022 were $3.696B, a 18.39% decline from 2021.

Teva Pharmaceutical Industries Receivables 2010-2024 | TEVA

  • Teva Pharmaceutical Industries receivables for 2024 were $3.059B, a 10.24% decline from 2023.
  • Teva Pharmaceutical Industries receivables for 2023 were $3.408B, a 7.79% decline from 2022.
  • Teva Pharmaceutical Industries receivables for 2022 were $3.696B, a 18.39% decline from 2021.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.2B
BridgeBio Pharma (BBIO)$6.9B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M